Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Enoxaparin Sodium Market Growth 2021-2026

  • LP 4603520
  • 126 Pages
  • July 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
According to this latest study, the 2021 growth of Enoxaparin Sodium will have significant change from previous year. By the most conservative estimates of global Enoxaparin Sodium market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2842.8 million in 2020. Over the next five years the Enoxaparin Sodium market will register a 8.6% CAGR in terms of revenue, the global market size will reach US$ 3948.1 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Enoxaparin Sodium market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

20 mg/0.2mL

30 mg/0.3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

100 mg/1mL

120 mg/0.8mL

150 mg/1mL

300mg/3mL

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Hospital

Clinic

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Sanofi

Teva

Techdow (Hepalink)

Fresenius Kabi

Rovi

Amphastar

Nanjing King-friend

Sandoz

Apotex

Hangzhou Jiuyuan Gene Engineering

Cipla

Taj Pharma

Chengdu Baiyu Pharmaceutical

Suzhou Erye Pharmaceutical

Changzhou Qianhong Bio-pharma

Hebei Changshan Biochemical Pharmaceutical

Beijing SL Pharmaceutical

Huadong Medicine

Bharat Serums

INTAS

LUPIN

Troikaa Pharmaceuticals

Aristopharma

Fosun Pharma

SciencePharma

PISA

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Enoxaparin Sodium Consumption 2016-2026

2.1.2 Enoxaparin Sodium Consumption CAGR by Region

2.2 Enoxaparin Sodium Segment by Type

2.2.1 20 mg/0.2mL

2.2.2 30 mg/0.3mL

2.2.3 40 mg/0.4mL

2.2.4 60 mg/0.6mL

2.2.5 80 mg/0.8mL

2.2.6 100 mg/1mL

2.2.7 120 mg/0.8mL

2.2.8 150 mg/1mL

2.2.9 300mg/3mL

2.3 Enoxaparin Sodium Sales by Type

2.3.1 Global Enoxaparin Sodium Sales Market Share by Type (2016-2021)

2.3.2 Global Enoxaparin Sodium Revenue and Market Share by Type (2016-2021)

2.3.3 Global Enoxaparin Sodium Sale Price by Type (2016-2021)

2.4 Enoxaparin Sodium Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Enoxaparin Sodium Sales by Application

2.5.1 Global Enoxaparin Sodium Sale Market Share by Application (2016-2021)

2.5.2 Global Enoxaparin Sodium Revenue and Market Share by Application (2016-2021)

2.5.3 Global Enoxaparin Sodium Sale Price by Application (2016-2021)

3 Global Enoxaparin Sodium by Company

3.1 Global Enoxaparin Sodium Sales Market Share by Company

3.1.1 Global Enoxaparin Sodium Sales by Company (2019-2021)

3.1.2 Global Enoxaparin Sodium Sales Market Share by Company (2019-2021)

3.2 Global Enoxaparin Sodium Revenue Market Share by Company

3.2.1 Global Enoxaparin Sodium Revenue by Company (2019-2021)

3.2.2 Global Enoxaparin Sodium Revenue Market Share by Company (2019-2021)

3.3 Global Enoxaparin Sodium Sale Price by Company

3.4 Global Manufacturers Enoxaparin Sodium Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Enoxaparin Sodium Product Location Distribution

3.4.2 Players Enoxaparin Sodium Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Enoxaparin Sodium by Region

4.1 Global Enoxaparin Sodium by Region

4.1.1 Global Enoxaparin Sodium Sales by Region

4.1.2 Global Enoxaparin Sodium Revenue by Region

4.2 Americas Enoxaparin Sodium Sales Growth

4.3 APAC Enoxaparin Sodium Sales Growth

4.4 Europe Enoxaparin Sodium Sales Growth

4.5 Middle East & Africa Enoxaparin Sodium Sales Growth

5 Americas

5.1 Americas Enoxaparin Sodium Sales by Country

5.1.1 Americas Enoxaparin Sodium Sales by Country (2016-2021)

5.1.2 Americas Enoxaparin Sodium Revenue by Country (2016-2021)

5.2 Americas Enoxaparin Sodium Sales by Type

5.3 Americas Enoxaparin Sodium Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Enoxaparin Sodium Sales by Region

6.1.1 APAC Enoxaparin Sodium Sales by Region (2016-2021)

6.1.2 APAC Enoxaparin Sodium Revenue by Region (2016-2021)

6.2 APAC Enoxaparin Sodium Sales by Type

6.3 APAC Enoxaparin Sodium Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Enoxaparin Sodium by Country

7.1.1 Europe Enoxaparin Sodium Sales by Country (2016-2021)

7.1.2 Europe Enoxaparin Sodium Revenue by Country (2016-2021)

7.2 Europe Enoxaparin Sodium Sales by Type

7.3 Europe Enoxaparin Sodium Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Enoxaparin Sodium by Country

8.1.1 Middle East & Africa Enoxaparin Sodium Sales by Country (2016-2021)

8.1.2 Middle East & Africa Enoxaparin Sodium Revenue by Country (2016-2021)

8.2 Middle East & Africa Enoxaparin Sodium Sales by Type

8.3 Middle East & Africa Enoxaparin Sodium Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Enoxaparin Sodium Distributors

10.3 Enoxaparin Sodium Customer

11 Global Enoxaparin Sodium Market Forecast

11.1 Global Enoxaparin Sodium Forecast by Region

11.1.1 Global Enoxaparin Sodium Forecast by Regions (2021-2026)

11.2.2 Global Enoxaparin Sodium Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Enoxaparin Sodium Forecast by Type

11.7 Global Enoxaparin Sodium Forecast by Application

12 Key Players Analysis

12.1 Sanofi

12.1.1 Sanofi Company Information

12.1.2 Sanofi Enoxaparin Sodium Product Offered

12.1.3 Sanofi Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Sanofi Main Business Overview

12.1.5 Sanofi Latest Developments

12.2 Teva

12.2.1 Teva Company Information

12.2.2 Teva Enoxaparin Sodium Product Offered

12.2.3 Teva Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Teva Main Business Overview

12.2.5 Teva Latest Developments

12.3 Techdow (Hepalink)

12.3.1 Techdow (Hepalink) Company Information

12.3.2 Techdow (Hepalink) Enoxaparin Sodium Product Offered

12.3.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Techdow (Hepalink) Main Business Overview

12.3.5 Techdow (Hepalink) Latest Developments

12.4 Fresenius Kabi

12.4.1 Fresenius Kabi Company Information

12.4.2 Fresenius Kabi Enoxaparin Sodium Product Offered

12.4.3 Fresenius Kabi Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Fresenius Kabi Main Business Overview

12.4.5 Fresenius Kabi Latest Developments

12.5 Rovi

12.5.1 Rovi Company Information

12.5.2 Rovi Enoxaparin Sodium Product Offered

12.5.3 Rovi Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Rovi Main Business Overview

12.5.5 Rovi Latest Developments

12.6 Amphastar

12.6.1 Amphastar Company Information

12.6.2 Amphastar Enoxaparin Sodium Product Offered

12.6.3 Amphastar Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Amphastar Main Business Overview

12.6.5 Amphastar Latest Developments

12.7 Nanjing King-friend

12.7.1 Nanjing King-friend Company Information

12.7.2 Nanjing King-friend Enoxaparin Sodium Product Offered

12.7.3 Nanjing King-friend Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Nanjing King-friend Main Business Overview

12.7.5 Nanjing King-friend Latest Developments

12.8 Sandoz

12.8.1 Sandoz Company Information

12.8.2 Sandoz Enoxaparin Sodium Product Offered

12.8.3 Sandoz Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Sandoz Main Business Overview

12.8.5 Sandoz Latest Developments

12.9 Apotex

12.9.1 Apotex Company Information

12.9.2 Apotex Enoxaparin Sodium Product Offered

12.9.3 Apotex Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Apotex Main Business Overview

12.9.5 Apotex Latest Developments

12.10 Hangzhou Jiuyuan Gene Engineering

12.10.1 Hangzhou Jiuyuan Gene Engineering Company Information

12.10.2 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Offered

12.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Hangzhou Jiuyuan Gene Engineering Main Business Overview

12.10.5 Hangzhou Jiuyuan Gene Engineering Latest Developments

12.11 Cipla

12.11.1 Cipla Company Information

12.11.2 Cipla Enoxaparin Sodium Product Offered

12.11.3 Cipla Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Cipla Main Business Overview

12.11.5 Cipla Latest Developments

12.12 Taj Pharma

12.12.1 Taj Pharma Company Information

12.12.2 Taj Pharma Enoxaparin Sodium Product Offered

12.12.3 Taj Pharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Taj Pharma Main Business Overview

12.12.5 Taj Pharma Latest Developments

12.13 Chengdu Baiyu Pharmaceutical

12.13.1 Chengdu Baiyu Pharmaceutical Company Information

12.13.2 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Offered

12.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Chengdu Baiyu Pharmaceutical Main Business Overview

12.13.5 Chengdu Baiyu Pharmaceutical Latest Developments

12.14 Suzhou Erye Pharmaceutical

12.14.1 Suzhou Erye Pharmaceutical Company Information

12.14.2 Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Offered

12.14.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Suzhou Erye Pharmaceutical Main Business Overview

12.14.5 Suzhou Erye Pharmaceutical Latest Developments

12.15 Changzhou Qianhong Bio-pharma

12.15.1 Changzhou Qianhong Bio-pharma Company Information

12.15.2 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Offered

12.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Changzhou Qianhong Bio-pharma Main Business Overview

12.15.5 Changzhou Qianhong Bio-pharma Latest Developments

12.16 Hebei Changshan Biochemical Pharmaceutical

12.16.1 Hebei Changshan Biochemical Pharmaceutical Company Information

12.16.2 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Offered

12.16.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Hebei Changshan Biochemical Pharmaceutical Main Business Overview

12.16.5 Hebei Changshan Biochemical Pharmaceutical Latest Developments

12.17 Beijing SL Pharmaceutical

12.17.1 Beijing SL Pharmaceutical Company Information

12.17.2 Beijing SL Pharmaceutical Enoxaparin Sodium Product Offered

12.17.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 Beijing SL Pharmaceutical Main Business Overview

12.17.5 Beijing SL Pharmaceutical Latest Developments

12.18 Huadong Medicine

12.18.1 Huadong Medicine Company Information

12.18.2 Huadong Medicine Enoxaparin Sodium Product Offered

12.18.3 Huadong Medicine Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.18.4 Huadong Medicine Main Business Overview

12.18.5 Huadong Medicine Latest Developments

12.19 Bharat Serums

12.19.1 Bharat Serums Company Information

12.19.2 Bharat Serums Enoxaparin Sodium Product Offered

12.19.3 Bharat Serums Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.19.4 Bharat Serums Main Business Overview

12.19.5 Bharat Serums Latest Developments

12.20 INTAS

12.20.1 INTAS Company Information

12.20.2 INTAS Enoxaparin Sodium Product Offered

12.20.3 INTAS Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.20.4 INTAS Main Business Overview

12.20.5 INTAS Latest Developments

12.21 LUPIN

12.21.1 LUPIN Company Information

12.21.2 LUPIN Enoxaparin Sodium Product Offered

12.21.3 LUPIN Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.21.4 LUPIN Main Business Overview

12.21.5 LUPIN Latest Developments

12.22 Troikaa Pharmaceuticals

12.22.1 Troikaa Pharmaceuticals Company Information

12.22.2 Troikaa Pharmaceuticals Enoxaparin Sodium Product Offered

12.22.3 Troikaa Pharmaceuticals Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.22.4 Troikaa Pharmaceuticals Main Business Overview

12.22.5 Troikaa Pharmaceuticals Latest Developments

12.23 Aristopharma

12.23.1 Aristopharma Company Information

12.23.2 Aristopharma Enoxaparin Sodium Product Offered

12.23.3 Aristopharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.23.4 Aristopharma Main Business Overview

12.23.5 Aristopharma Latest Developments

12.24 Fosun Pharma

12.24.1 Fosun Pharma Company Information

12.24.2 Fosun Pharma Enoxaparin Sodium Product Offered

12.24.3 Fosun Pharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.24.4 Fosun Pharma Main Business Overview

12.24.5 Fosun Pharma Latest Developments

12.25 SciencePharma

12.25.1 SciencePharma Company Information

12.25.2 SciencePharma Enoxaparin Sodium Product Offered

12.25.3 SciencePharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.25.4 SciencePharma Main Business Overview

12.25.5 SciencePharma Latest Developments

12.26 PISA

12.26.1 PISA Company Information

12.26.2 PISA Enoxaparin Sodium Product Offered

12.26.3 PISA Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2021)

12.26.4 PISA Main Business Overview

12.26.5 PISA Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Enoxaparin Sodium Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of 20 mg/0.2mL

Table 3. Major Players of 30 mg/0.3mL

Table 4. Major Players of 40 mg/0.4mL

Table 5. Major Players of 60 mg/0.6mL

Table 6. Major Players of 80 mg/0.8mL

Table 7. Major Players of 100 mg/1mL

Table 8. Major Players of 120 mg/0.8mL

Table 9. Major Players of 150 mg/1mL

Table 10. Major Players of 300mg/3mL

Table 11. Global Enoxaparin Sodium Sales by Type (2016-2021) & (M Units)

Table 12. Global Enoxaparin Sodium Sales Market Share by Type (2016-2021)

Table 13. Global Enoxaparin Sodium Revenue by Type (2016-2021) & ($ million)

Table 14. Global Enoxaparin Sodium Revenue Market Share by Type (2016-2021)

Table 15. Global Enoxaparin Sodium Sale Price by Type (2016-2021)

Table 16. Global Enoxaparin Sodium Sales by Application (2016-2021) & (M Units)

Table 17. Global Enoxaparin Sodium Sales Market Share by Application (2016-2021)

Table 18. Global Enoxaparin Sodium Value by Application (2016-2021)

Table 19. Global Enoxaparin Sodium Revenue Market Share by Application (2016-2021)

Table 20. Global Enoxaparin Sodium Sale Price by Application (2016-2021)

Table 21. Global Enoxaparin Sodium Sales by Company (2019-2021) & (M Units)

Table 22. Global Enoxaparin Sodium Sales Market Share by Company (2019-2021)

Table 23. Global Enoxaparin Sodium Revenue by Company (2019-2021) ($ Millions)

Table 24. Global Enoxaparin Sodium Revenue Market Share by Company (2019-2021)

Table 25. Global Enoxaparin Sodium Sale Price by Company (2019-2021)

Table 26. Key Manufacturers Enoxaparin Sodium Producing Area Distribution and Sales Area

Table 27. Players Enoxaparin Sodium Products Offered

Table 28. Enoxaparin Sodium Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 29. New Products and Potential Entrants

Table 30. Mergers & Acquisitions, Expansion

Table 31. Global Enoxaparin Sodium Sales by Region (2016-2021) (M Units)

Table 32. Global Enoxaparin Sodium Sales Market Share by Region (2016-2021)

Table 33. Global Enoxaparin Sodium Revenue by Region (2016-2021) & ($ Millions)

Table 34. Global Enoxaparin Sodium Revenue Market Share by Region (2016-2021)

Table 35. Americas Enoxaparin Sodium Sales by Country (2016-2021) & (M Units)

Table 36. Americas Enoxaparin Sodium Sales Market Share by Country (2016-2021)

Table 37. Americas Enoxaparin Sodium Revenue by Country (2016-2021) & ($ Millions)

Table 38. Americas Enoxaparin Sodium Revenue Market Share by Country (2016-2021)

Table 39. Americas Enoxaparin Sodium Sales by Type (2016-2021) & (M Units)

Table 40. Americas Enoxaparin Sodium Sales Market Share by Type (2016-2021)

Table 41. Americas Enoxaparin Sodium Sales by Application (2016-2021) & (M Units)

Table 42. Americas Enoxaparin Sodium Sales Market Share by Application (2016-2021)

Table 43. APAC Enoxaparin Sodium Sales by Region (2016-2021) & (M Units)

Table 44. APAC Enoxaparin Sodium Sales Market Share by Region (2016-2021)

Table 45. APAC Enoxaparin Sodium Revenue by Region (2016-2021) & ($ Millions)

Table 46. APAC Enoxaparin Sodium Revenue Market Share by Region (2016-2021)

Table 47. APAC Enoxaparin Sodium Sales by Type (2016-2021) & (M Units)

Table 48. APAC Enoxaparin Sodium Sales Market Share by Type (2016-2021)

Table 49. APAC Enoxaparin Sodium Sales by Application (2016-2021) & (M Units)

Table 50. APAC Enoxaparin Sodium Sales Market Share by Application (2016-2021)

Table 51. Europe Enoxaparin Sodium Sales by Country (2016-2021) & (M Units)

Table 52. Europe Enoxaparin Sodium Sales Market Share by Country (2016-2021)

Table 53. Europe Enoxaparin Sodium Revenue by Country (2016-2021) & ($ Millions)

Table 54. Europe Enoxaparin Sodium Revenue Market Share by Country (2016-2021)

Table 55. Europe Enoxaparin Sodium Sales by Type (2016-2021) & (M Units)

Table 56. Europe Enoxaparin Sodium Sales Market Share by Type (2016-2021)

Table 57. Europe Enoxaparin Sodium Sales by Application (2016-2021) & (M Units)

Table 58. Europe Enoxaparin Sodium Sales Market Share by Application (2016-2021)

Table 59. Middle East & Africa Enoxaparin Sodium Sales by Country (2016-2021) & (M Units)

Table 60. Middle East & Africa Enoxaparin Sodium Sales Market Share by Country (2016-2021)

Table 61. Middle East & Africa Enoxaparin Sodium Revenue by Country (2016-2021) & ($ Millions)

Table 62. Middle East & Africa Enoxaparin Sodium Revenue Market Share by Country (2016-2021)

Table 63. Middle East & Africa Enoxaparin Sodium Sales by Type (2016-2021) & (M Units)

Table 64. Middle East & Africa Enoxaparin Sodium Sales Market Share by Type (2016-2021)

Table 65. Middle East & Africa Enoxaparin Sodium Sales by Application (2016-2021) & (M Units)

Table 66. Middle East & Africa Enoxaparin Sodium Sales Market Share by Application (2016-2021)

Table 67. Key and Potential Regions of Enoxaparin Sodium

Table 68. Key Application and Potential Industries of Enoxaparin Sodium

Table 69. Key Challenges of Enoxaparin Sodium

Table 70. Key Trends of Enoxaparin Sodium

Table 71. Enoxaparin Sodium Distributors List

Table 72. Enoxaparin Sodium Customer List

Table 73. Global Enoxaparin Sodium Sales Forecast by Region (2021-2026) & (M Units)

Table 74. Global Enoxaparin Sodium Consumption Market Forecast by Region

Table 75. Global Enoxaparin Sodium Revenue Forecast by Region (2021-2026) & ($ millions)

Table 76. Global Enoxaparin Sodium Revenue Market Share Forecast by Region (2021-2026)

Table 77. Americas Enoxaparin Sodium Sales Forecast by Country (2021-2026) & (M Units)

Table 78. Americas Enoxaparin Sodium Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. APAC Enoxaparin Sodium Sales Forecast by Region (2021-2026) & (M Units)

Table 80. APAC Enoxaparin Sodium Revenue Forecast by Region (2021-2026) & ($ millions)

Table 81. Europe Enoxaparin Sodium Sales Forecast by Country (2021-2026) & (M Units)

Table 82. Europe Enoxaparin Sodium Revenue Forecast by Country (2021-2026) & ($ millions)

Table 83. Middle East & Africa Enoxaparin Sodium Sales Forecast by Country (2021-2026) & (M Units)

Table 84. Middle East & Africa Enoxaparin Sodium Revenue Forecast by Country (2021-2026) & ($ millions)

Table 85. Global Enoxaparin Sodium Sales Forecast by Type (2021-2026) & (M Units)

Table 86. Global Enoxaparin Sodium Sales Market Share Forecast by Type (2021-2026)

Table 87. Global Enoxaparin Sodium Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 88. Global Enoxaparin Sodium Revenue Market Share Forecast by Type (2021-2026)

Table 89. Global Enoxaparin Sodium Sales Forecast by Application (2021-2026) & (M Units)

Table 90. Global Enoxaparin Sodium Sales Market Share Forecast by Application (2021-2026)

Table 91. Global Enoxaparin Sodium Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 92. Global Enoxaparin Sodium Revenue Market Share Forecast by Application (2021-2026)

Table 93. Sanofi Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 94. Sanofi Enoxaparin Sodium Product Offered

Table 95. Sanofi Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 96. Sanofi Main Business

Table 97. Sanofi Latest Developments

Table 98. Teva Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 99. Teva Enoxaparin Sodium Product Offered

Table 100. Teva Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 101. Teva Main Business

Table 102. Teva Latest Developments

Table 103. Techdow (Hepalink) Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 104. Techdow (Hepalink) Enoxaparin Sodium Product Offered

Table 105. Techdow (Hepalink) Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 106. Techdow (Hepalink) Main Business

Table 107. Techdow (Hepalink) Latest Developments

Table 108. Fresenius Kabi Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 109. Fresenius Kabi Enoxaparin Sodium Product Offered

Table 110. Fresenius Kabi Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 111. Fresenius Kabi Main Business

Table 112. Fresenius Kabi Latest Developments

Table 113. Rovi Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 114. Rovi Enoxaparin Sodium Product Offered

Table 115. Rovi Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 116. Rovi Main Business

Table 117. Rovi Latest Developments

Table 118. Amphastar Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 119. Amphastar Enoxaparin Sodium Product Offered

Table 120. Amphastar Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 121. Amphastar Main Business

Table 122. Amphastar Latest Developments

Table 123. Nanjing King-friend Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 124. Nanjing King-friend Enoxaparin Sodium Product Offered

Table 125. Nanjing King-friend Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 126. Nanjing King-friend Main Business

Table 127. Nanjing King-friend Latest Developments

Table 128. Sandoz Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 129. Sandoz Enoxaparin Sodium Product Offered

Table 130. Sandoz Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 131. Sandoz Main Business

Table 132. Sandoz Latest Developments

Table 133. Apotex Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 134. Apotex Enoxaparin Sodium Product Offered

Table 135. Apotex Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 136. Apotex Main Business

Table 137. Apotex Latest Developments

Table 138. Hangzhou Jiuyuan Gene Engineering Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 139. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Offered

Table 140. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 141. Hangzhou Jiuyuan Gene Engineering Main Business

Table 142. Hangzhou Jiuyuan Gene Engineering Latest Developments

Table 143. Cipla Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 144. Cipla Enoxaparin Sodium Product Offered

Table 145. Cipla Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 146. Cipla Main Business

Table 147. Cipla Latest Developments

Table 148. Taj Pharma Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 149. Taj Pharma Enoxaparin Sodium Product Offered

Table 150. Taj Pharma Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 151. Taj Pharma Main Business

Table 152. Taj Pharma Latest Developments

Table 153. Chengdu Baiyu Pharmaceutical Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 154. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Offered

Table 155. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 156. Chengdu Baiyu Pharmaceutical Main Business

Table 157. Chengdu Baiyu Pharmaceutical Latest Developments

Table 158. Suzhou Erye Pharmaceutical Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 159. Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Offered

Table 160. Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 161. Suzhou Erye Pharmaceutical Main Business

Table 162. Suzhou Erye Pharmaceutical Latest Developments

Table 163. Changzhou Qianhong Bio-pharma Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 164. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Offered

Table 165. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 166. Changzhou Qianhong Bio-pharma Main Business

Table 167. Changzhou Qianhong Bio-pharma Latest Developments

Table 168. Hebei Changshan Biochemical Pharmaceutical Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 169. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Offered

Table 170. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 171. Hebei Changshan Biochemical Pharmaceutical Main Business

Table 172. Hebei Changshan Biochemical Pharmaceutical Latest Developments

Table 173. Beijing SL Pharmaceutical Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 174. Beijing SL Pharmaceutical Enoxaparin Sodium Product Offered

Table 175. Beijing SL Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 176. Beijing SL Pharmaceutical Main Business

Table 177. Beijing SL Pharmaceutical Latest Developments

Table 178. Huadong Medicine Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 179. Huadong Medicine Enoxaparin Sodium Product Offered

Table 180. Huadong Medicine Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 181. Huadong Medicine Main Business

Table 182. Huadong Medicine Latest Developments

Table 183. Bharat Serums Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 184. Bharat Serums Enoxaparin Sodium Product Offered

Table 185. Bharat Serums Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 186. Bharat Serums Main Business

Table 187. Bharat Serums Latest Developments

Table 188. INTAS Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 189. INTAS Enoxaparin Sodium Product Offered

Table 190. INTAS Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 191. INTAS Main Business

Table 192. INTAS Latest Developments

Table 193. LUPIN Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 194. LUPIN Enoxaparin Sodium Product Offered

Table 195. LUPIN Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 196. LUPIN Main Business

Table 197. LUPIN Latest Developments

Table 198. Troikaa Pharmaceuticals Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 199. Troikaa Pharmaceuticals Enoxaparin Sodium Product Offered

Table 200. Troikaa Pharmaceuticals Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 201. Troikaa Pharmaceuticals Main Business

Table 202. Troikaa Pharmaceuticals Latest Developments

Table 203. Aristopharma Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 204. Aristopharma Enoxaparin Sodium Product Offered

Table 205. Aristopharma Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 206. Aristopharma Main Business

Table 207. Aristopharma Latest Developments

Table 208. Fosun Pharma Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 209. Fosun Pharma Enoxaparin Sodium Product Offered

Table 210. Fosun Pharma Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 211. Fosun Pharma Main Business

Table 212. Fosun Pharma Latest Developments

Table 213. SciencePharma Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 214. SciencePharma Enoxaparin Sodium Product Offered

Table 215. SciencePharma Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 216. SciencePharma Main Business

Table 217. SciencePharma Latest Developments

Table 218. PISA Basic Information, Enoxaparin Sodium Manufacturing Base, Sales Area and Its Competitors

Table 219. PISA Enoxaparin Sodium Product Offered

Table 220. PISA Enoxaparin Sodium Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 221. PISA Main Business

Table 222. PISA Latest Developments

List of Figures

Figure 1. Picture of Enoxaparin Sodium

Figure 2. Enoxaparin Sodium Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Enoxaparin Sodium Sales Growth Rate 2016-2026 (M Units)

Figure 7. Global Enoxaparin Sodium Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Enoxaparin Sodium Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of 20 mg/0.2mL

Figure 10. Product Picture of 30 mg/0.3mL

Figure 11. Product Picture of 40 mg/0.4mL

Figure 12. Product Picture of 60 mg/0.6mL

Figure 13. Product Picture of 80 mg/0.8mL

Figure 14. Product Picture of 100 mg/1mL

Figure 15. Product Picture of 120 mg/0.8mL

Figure 16. Product Picture of 150 mg/1mL

Figure 17. Product Picture of 300mg/3mL

Figure 18. Global Enoxaparin Sodium Sales Market Share by Type in 2020

Figure 19. Global Enoxaparin Sodium Revenue Market Share by Type (2016-2021)

Figure 20. Enoxaparin Sodium Consumed in Hospital

Figure 21. Global Enoxaparin Sodium Market: Hospital (2016-2021) & (M Units)

Figure 22. Enoxaparin Sodium Consumed in Clinic

Figure 23. Global Enoxaparin Sodium Market: Clinic (2016-2021) & (M Units)

Figure 24. Enoxaparin Sodium Consumed in Others

Figure 25. Global Enoxaparin Sodium Market: Others (2016-2021) & (M Units)

Figure 26. Global Enoxaparin Sodium Sales Market Share by Application (2016-2021)

Figure 27. Global Enoxaparin Sodium Revenue Market Share by Application in 2020

Figure 28. Enoxaparin Sodium Revenue Market by Company in 2020 ($ Million)

Figure 29. Global Enoxaparin Sodium Revenue Market Share by Company in 2020

Figure 30. Global Enoxaparin Sodium Sales Market Share by Regions (2016-2021)

Figure 31. Global Enoxaparin Sodium Revenue Market Share by Region in 2020

Figure 32. Americas Enoxaparin Sodium Sales 2016-2021 (M Units)

Figure 33. Americas Enoxaparin Sodium Revenue 2016-2021 ($ Millions)

Figure 34. APAC Enoxaparin Sodium Sales 2016-2021 (M Units)

Figure 35. APAC Enoxaparin Sodium Revenue 2016-2021 ($ Millions)

Figure 36. Europe Enoxaparin Sodium Sales 2016-2021 (M Units)

Figure 37. Europe Enoxaparin Sodium Revenue 2016-2021 ($ Millions)

Figure 38. Middle East & Africa Enoxaparin Sodium Sales 2016-2021 (M Units)

Figure 39. Middle East & Africa Enoxaparin Sodium Revenue 2016-2021 ($ Millions)

Figure 40. Americas Enoxaparin Sodium Sales Market Share by Country in 2020

Figure 41. Americas Enoxaparin Sodium Revenue Market Share by Country in 2020

Figure 42. Americas Enoxaparin Sodium Sales Market Share by Type in 2020

Figure 43. Americas Enoxaparin Sodium Sales Market Share by Application in 2020

Figure 44. United States Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 45. Canada Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 46. Mexico Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 47. Brazil Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 48. APAC Enoxaparin Sodium Sales Market Share by Region in 2020

Figure 49. APAC Enoxaparin Sodium Revenue Market Share by Regions in 2020

Figure 50. APAC Enoxaparin Sodium Sales Market Share by Type in 2020

Figure 51. APAC Enoxaparin Sodium Sales Market Share by Application in 2020

Figure 52. China Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 53. Japan Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 54. Korea Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 55. Southeast Asia Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 56. India Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 57. Australia Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 58. Europe Enoxaparin Sodium Sales Market Share by Country in 2020

Figure 59. Europe Enoxaparin Sodium Revenue Market Share by Country in 2020

Figure 60. Europe Enoxaparin Sodium Sales Market Share by Type in 2020

Figure 61. Europe Enoxaparin Sodium Sales Market Share by Application in 2020

Figure 62. Germany Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 63. France Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 64. UK Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 65. Italy Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 66. Russia Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 67. Middle East & Africa Enoxaparin Sodium Sales Market Share by Country in 2020

Figure 68. Middle East & Africa Enoxaparin Sodium Revenue Market Share by Country in 2020

Figure 69. Middle East & Africa Enoxaparin Sodium Sales Market Share by Type in 2020

Figure 70. Middle East & Africa Enoxaparin Sodium Sales Market Share by Application in 2020

Figure 71. Egypt Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 72. South Africa Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 73. Israel Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 74. Turkey Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 75. GCC Country Enoxaparin Sodium Revenue Growth 2016-2021 ($ Millions)

Figure 76. Channels of Distribution

Figure 77. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390